There is more psychedelic research happening today than ever before, but is anyone collecting it all into one place? And can we find trends in all that data?
In this episode, David interviews Floris Wolswijk: senior project manager at Delphi; co-founder of FLO coaching; and founder of Blossom, an online informational hub collecting psychedelic courses, trials, companies, and over 2000 categorized research articles.
When Wolswijk began Blossom, he was barely able to fill a weekly newsletter, and now he’s adding a new study nearly every day, perfectly illustrating the exponential growth in psychedelic research. He talks about why so much research is happening (and why more isn’t), the trends he’s seen, the benefit in research changing people’s minds, and what he hopes for in the future. What can the research community learn from existing real world evidence, and how can retreat centers and underground communities contribute?
He also discusses:
- What culture is like in the Netherlands, where psilocybin truffles are legal
- Drug development and the possibilities of adjusting existing molecules
- What we can learn from the Lykos and FDA situation
- The economics of psychedelics and how insurance will likely be the next big conversation
- His work with FLO coaching, and how coaching, acceptance and commitment therapy, and psilocybin can work together
and more!
Links
Why Did the FDA Reject MDMA-Assisted Therapy for PTSD?, featuring: Ingmar Gorman, Ph.D.
Painscience.com: A fascinating landmark study of placebo surgery for knee osteoarthritis
Psychedelicalpha.com: The Psychedelic Drug Development Pipeline Bullseye Chart
The Economics of Psychedelics, featuring: Elliot Marseille, DrPH, MPP
